Bone Biologics Corp (BBLG) Stock Price, Quote & News

Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthoped...

Industry: Medical Devices

Sector: Healthcare

Phone: 781 552 4452

Website: www.bonebiologics.com

Address:

2 Burlington Woods Drive, Suite 100, Burlington, United States

Will2ride1 Jul. 9 at 7:56 PM

$BBLG starter taken

0 · Reply

chickenugget Jul. 9 at 6:35 PM

$BBLG doubled

0 · Reply

i_like_bb_stock Jul. 9 at 5:29 PM

$BBLG found its bottom still low floater post offering , turning up nicely

0 · Reply

JamesTek2025 Jul. 9 at 3:17 AM

$BBLG I can see this retesting $5.10 to $5.40 by end of the month. Still holding a nice chunk of shares.

0 · Reply

Blackjack_trail Jul. 8 at 5:03 PM

$BBLG it has a nice daily range, and is somewhat predictable. It’s a great day trading stock.

0 · Reply

BeachbumInvestor Jul. 8 at 3:58 PM

$BBLG EESH.... Not too good.

0 · Reply

Thespectator Jul. 8 at 2:11 PM

$BBLG people who think they are getting a great deal at $3 will be in a rude awakening soon, the hedge funds already made millions from the p&d on June 27 and covered with the cheap shares from the offering, in reality their cost basis is zero, thats’s why they can keep shorting without any concern

1 · Reply

Thespectator Jul. 8 at 1:52 PM

$BBLG the hedge funds will bring it to non compliance to r/s again, should happen within a year then magically patent approval news will just hit in time for them to pump it up rinse repeat

1 · Reply

chickenugget Jul. 8 at 9:39 AM

$BBLG added

0 · Reply

Vikingmilkman Jul. 8 at 5:07 AM

$BBLG load load the boat, yes or yes?

0 · Reply

Bone Biologics Announces Closing of $5.0 Million Public Offering

Jun 27, 2025, 10:23 AM EDT - 12 days ago

Why Is Bone Biologics Stock Surging On Friday?

Jun 27, 2025, 9:10 AM EDT - 12 days ago

Bone Biologics Announces Pricing of $5.0 Million Public Offering

Jun 27, 2025, 7:00 AM EDT - 12 days ago

Bone Biologics Files Patent Application for Bone Regeneration Technology

Jun 26, 2025, 4:20 PM EDT - 13 days ago

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Jun 6, 2025, 8:00 AM EDT - 4 weeks ago

Bone Biologics Announces 1-for-6 Reverse Stock Split

Oct 21, 2024, 8:00 AM EDT - 9 months ago

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Sep 4, 2024, 8:00 AM EDT - 11 months ago

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 2, 2024, 8:00 AM EDT - 1 year ago

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Jun 20, 2024, 8:00 AM EDT - 1 year ago

First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion

Mar 6, 2024, 4:15 PM EST - 1 year ago

Bone Biologics Announces Closing of $2.0 Million Public Offering

Mar 4, 2024, 9:15 AM EST - 1 year ago

Bone Biologics Announces Pricing of $2.0 Million Public Offering

Mar 1, 2024, 8:00 AM EST - 1 year ago

Bone Biologics Reports Progress With NB1 Clinical Program

Jan 11, 2024, 8:00 AM EST - 1 year ago

Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors

Dec 18, 2023, 8:00 AM EST - 1 year ago

Bone Biologics Announces 1-for-8 Reverse Stock Split

Nov 20, 2023, 12:38 PM EST - 1 year ago

Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 16, 2023, 4:43 PM EST - 1 year ago

Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 26, 2023, 8:00 AM EDT - 1 year ago

Bone Biologics Provides Scientific Update on NB1 Bone Graft Device

Jun 21, 2023, 7:49 AM EDT - 2 years ago

Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Bone Biologics (NASDAQ:BBLG), Fresh2 Group (NASDAQ:FRES)

VTGN

Jun 15, 2023, 9:22 AM EDT - 2 years ago

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount

Jun 14, 2023, 11:30 PM EDT - 2 years ago

Bone Biologics Prices $5.0 Million Underwritten Public Offering

Jun 6, 2023, 1:00 PM EDT - 2 years ago

Bone Biologics Effects 1-for-30 Reverse Stock Split

Apr 11, 2023, 8:00 AM EDT - 2 years ago

Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

Jan 26, 2023, 8:30 AM EST - 2 years ago

Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

Oct 25, 2022, 8:00 AM EDT - 2 years ago

Bone Biologics CEO Issues Letter to Stockholders

Oct 13, 2022, 9:00 AM EDT - 2 years ago

WallachBeth Capital Announces Closing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 12, 2022, 4:05 PM EDT - 2 years ago

Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:52 AM EDT - 2 years ago

CORRECTING and REPLACING Bone Biologics Prices $5,100,000 Underwritten Public Offering

Oct 7, 2022, 10:16 AM EDT - 2 years ago

WallachBeth Capital Announces Pricing of Bone Biologics $5,100,000 Underwritten Public Offering

Oct 7, 2022, 8:00 AM EDT - 2 years ago

Bone Biologics Prices $5,100,000 Million Underwritten Public Offering

Mar 23, 2022, 8:00 AM EDT - 3 years ago

Bone Biologics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Mar 7, 2022, 7:00 AM EST - 3 years ago

Bone Biologics Enters into Supply Agreement with MTF Biologics for Demineralized Bone Matrix

Jan 10, 2022, 10:38 AM EST - 3 years ago

Why Are Bone Biologics Shares Surging On Monday?

Jan 5, 2022, 8:30 AM EST - 3 years ago

Bone Biologics to Present at the H.C. Wainwright BioConnect Virtual Conference

Oct 18, 2021, 8:30 AM EDT - 4 years ago

Bone Biologics Corp. Announces Closing of Public Offering and Uplisting to Nasdaq

Oct 15, 2021, 12:00 PM EDT - 4 years ago

WallachBeth Capital Announces Completion of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering

Oct 13, 2021, 1:43 PM EDT - 4 years ago

WallachBeth Capital announces pricing of Bone Biologics Corp. (NASDAQ: BBLG) $7.9 million Public Offering and Uplisting to the NASDAQ Capital Market

Oct 13, 2021, 12:25 PM EDT - 4 years ago

Bone Biologics Corp. Announces Pricing of $7.9 million Public Offering; Uplisting to the Nasdaq Capital Market and Reverse Stock Split

Will2ride1 Jul. 9 at 7:56 PM

$BBLG starter taken

0 · Reply

chickenugget Jul. 9 at 6:35 PM

$BBLG doubled

0 · Reply

i_like_bb_stock Jul. 9 at 5:29 PM

$BBLG found its bottom still low floater post offering , turning up nicely

0 · Reply

JamesTek2025 Jul. 9 at 3:17 AM

$BBLG I can see this retesting $5.10 to $5.40 by end of the month. Still holding a nice chunk of shares.

0 · Reply

Blackjack_trail Jul. 8 at 5:03 PM

$BBLG it has a nice daily range, and is somewhat predictable. It’s a great day trading stock.

0 · Reply

BeachbumInvestor Jul. 8 at 3:58 PM

$BBLG EESH.... Not too good.

0 · Reply

Thespectator Jul. 8 at 2:11 PM

1 · Reply

Thespectator Jul. 8 at 1:52 PM

$BBLG the hedge funds will bring it to non compliance to r/s again, should happen within a year then magically patent approval news will just hit in time for them to pump it up rinse repeat

1 · Reply

chickenugget Jul. 8 at 9:39 AM

$BBLG added

0 · Reply

Vikingmilkman Jul. 8 at 5:07 AM

$BBLG load load the boat, yes or yes?

0 · Reply

ImCrazy Jul. 7 at 6:43 PM

$BBLG innnn

0 · Reply

i_like_bb_stock Jul. 7 at 5:27 PM

$BBLG in for a starter here very oversold , think a nice bounce is coming

0 · Reply

FWM23 Jul. 7 at 4:04 PM

$BBLG I’m officially out ..fuck this company

0 · Reply

tyrus6 Jul. 7 at 3:10 PM

$ICU WHALE alert! 13G filing I see you there, Mitch! (Mitch has an itch. For ICU.) Here’s what I found on Mitchell P. Kopin (often filing with Intracoastal Capital LLC or alongside Daniel B. Asher), who recently disclosed a 9.99% stake in SeaStar Medical (ICU): --- 👤 Professional Background Founder of Cranshire Capital Advisors LLC (est. 1996) and currently President of Cranshire Capital LP, a private investment firm . **Former President of Downsview Capital, Inc.** . Education: Undergraduate degree from the U. of Illinois and graduate degree from Kellogg School of Management . --- 📈 Investment Strategy & History Mitchell Kopin frequently targets ~5–10% passive stakes in small-cap biotech, med-tech, and tech companies via Schedule 13G filings: Bone Biologics ($BBLG) – 9.99% stake (153K shares) filed June 27, 2025 . Ascent Solar ($ASTI) – 9.99% stake (318K shares) on June 27, 2025 . Processa Pharmaceuticals ($PCSA) – 9.99% on June 17, 2025 . Mitch also scored on $SILO

1 · Reply

ALEXCORO Jul. 7 at 3:07 PM

$BBLG What a rubbish and scam company, friends...we're going to lose everything here...just give it a go...thieves

0 · Reply

FWM23 Jul. 7 at 2:40 PM

$BBLG wtf is happeninggggggg…pump this shit

0 · Reply

Thespectator Jul. 7 at 2:20 PM

$BBLG welp pumpers are gone, was hoping for another chance to short 😢

1 · Reply

FWM23 Jul. 7 at 12:41 PM

$BBLG this sucks

0 · Reply

PaulLaurent Jul. 6 at 5:55 PM

🧨📈 Potential Squeeze Stocks 📈🧨 $WHLR $LUCY $BBLG $OBLG $HUSA

0 · Reply

FWM23 Jul. 5 at 2:34 PM

$BBLG 284828822 next week

2 · Reply

BeachbumInvestor Jul. 3 at 6:16 PM

$BBLG ugh. $3 next week. .. hopefully stabilize after that

0 · Reply

BeachbumInvestor Jul. 3 at 2:42 PM

$MGRX grab opportunity when available... $GZIC $BBLG

0 · Reply

Market Cap	1.90M
Revenue (ttm)	0.00
Net Income (ttm)	-4.11M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	90,300
Avg Vol	618,660
Day's Range	N/A - N/A
Shares Out	545,000.00
Stochastic %K	3%
Beta	0.69
Analysts	Strong Buy
Price Target	$22.50